tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Personalis Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsPersonalis Reports Q2 2025 Financial Results
7d ago
Personalis: Buy Rating Amidst Challenges and Opportunities in MRD Growth
Premium
Ratings
Personalis: Buy Rating Amidst Challenges and Opportunities in MRD Growth
7d ago
Personalis reports Q2 EPS (23c), consensus (24c)
Premium
The Fly
Personalis reports Q2 EPS (23c), consensus (24c)
7d ago
Personalis Expands Agreement with Tempus AI for Cancer Test
PremiumCompany AnnouncementsPersonalis Expands Agreement with Tempus AI for Cancer Test
1M ago
Personalis expands Tempus AI strategic collaboration
Premium
The Fly
Personalis expands Tempus AI strategic collaboration
1M ago
Personalis’ NeXT Personal predicts cervical cancer recurrence risk
Premium
The Fly
Personalis’ NeXT Personal predicts cervical cancer recurrence risk
2M ago
Personalis initiated with a Buy at Guggenheim
PremiumThe FlyPersonalis initiated with a Buy at Guggenheim
3M ago
Personalis Q1 2025 Earnings: Growth and Strategic Advances
Premium
Company Announcements
Personalis Q1 2025 Earnings: Growth and Strategic Advances
3M ago
Personalis Inc.: Strong Financial Performance and Promising Future Prospects Drive Buy Rating
Premium
Ratings
Personalis Inc.: Strong Financial Performance and Promising Future Prospects Drive Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100